Trial · NCT01033773
Stop Emergency Room Visits for Hyperglycemia Project - District of Columbia (DC)
NCT01033773, Not applicable, Completed, Medstar Health Research Institute; results first posted 2020-10-05
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Stop Emergency Room Visits for Hyperglycemia Project - District of Columbia (DC). Trials, record NCT01033773. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01033773
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Stop Emergency Room Visits for Hyperglycemia Project - District of Columbia (DC)
- NCT number
- NCT01033773
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 86 participants, actual
- Lead sponsor
- Medstar Health Research Institute
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
Antihyperglycemic medication guideline for management of uncontrolled hyperglycemia presenting to the ED using metformin, sulfonylurea and/or insulin, Diabetes survival skills self-management education
- First posted
- 2009-12-16
- Last updated
- 2020-10-05
- Results first posted
- 2020-10-05
Source ClinicalTrials.gov
Registered outcomes3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Total Number of Hypoglycemia Events (Blood Glucose < 60mg/dL) Within 24 Hours of Baseline Visit | 24 hours | Total Number of hypoglycemic events defined as Blood Glucose \< 60 within 24 hours of index emergency room visit (baseline) |
| Secondary | Change in Mean Blood Glucose From Time of Presentation to Emergency Room to End of Intervention 30 Days From Baseline | 30 days | Mean difference in of blood glucose in mg/dl between baseline mean BG and end of intervention mean BG 30 days from baseline |
| Secondary | Change in Hemoglobin A1C From Baseline to End of Intervention at 30 Days | 30 days | difference between mean hemoglobin A1C at baseline and mean Hemoglobin A1C to end of intervention |
Source ClinicalTrials.gov
Outcomes3
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Total Number of Hypoglycemia Events (Blood Glucose < 60mg/dL) Within 24 Hours of Baseline Visit | 24 hours | events | NUMBER | |
| SECONDARY | Change in Mean Blood Glucose From Time of Presentation to Emergency Room to End of Intervention 30 Days From Baseline | 30 days | This data was only available for 51 patients therefore only 51 patients' results were analyzed. | mg/dl | MEAN |
| SECONDARY | Change in Hemoglobin A1C From Baseline to End of Intervention at 30 Days | 30 days | Only 46 patients had a baseline and end of intervention A1C available therefore only 46 participants are included in the data | percentage of hemoglobin A1C | MEAN |
Source ClinicalTrials.gov
Results by group5
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Total Number of Hypoglycemia Events (Blood Glucose < 60mg/dL) Within 24 Hours of Baseline Visit | Intervention | 0 | events | ||
| Change in Mean Blood Glucose From Time of Presentation to Emergency Room to End of Intervention 30 Days From Baseline | Intervention | Mean BG at baseline | 356 | Standard Deviation 110 | mg/dl |
| Change in Mean Blood Glucose From Time of Presentation to Emergency Room to End of Intervention 30 Days From Baseline | Intervention | Mean BG at end of intervention | 183 | Standard Deviation 103 | mg/dl |
| Change in Hemoglobin A1C From Baseline to End of Intervention at 30 Days | Intervention | Mean baseline A1C | 12.0 | Standard Deviation 1.5 | percentage of hemoglobin A1C |
| Change in Hemoglobin A1C From Baseline to End of Intervention at 30 Days | Intervention | Mean end of intervention A1C | 11.6 | Standard Deviation 1.6 | percentage of hemoglobin A1C |
Source ClinicalTrials.gov
Participant flow3
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Diabetes Education and Medication Management | 86 | |
| Overall Study | COMPLETED | Diabetes Education and Medication Management | 51 | |
| Overall Study | NOT COMPLETED | Diabetes Education and Medication Management | 35 |
Source ClinicalTrials.gov
Adverse events1
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Hypoglycemia | Endocrine disorders | Intervention | 14 | 86 | 26 |
Source ClinicalTrials.gov
Adverse event totals3
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Intervention | 0 | 86 |
| Total, other adverse events | Intervention | 14 | 86 |
| Total, serious adverse events | Intervention | 0 | 86 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01033773
GET https://conductscience.org/api/trials/v1/NCT01033773/registered